Michael P. Kane

The University of Texas MD Anderson Cancer Center · US

Area of research

Endocrinology, Diabetes and Metabolism · Oncology

Research interest

Research interests include Diabetes Treatment and Management, Diabetes Management and Research, Hyperglycemia and glycemic control in critically ill and hospitalized patients, and Cancer Treatment and Pharmacology.

h-index

citations

2,829

works

155

NIH funding

—

primary concept

—

✉ Find email ↗

Recent publications

Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer

Proceedings of the National Academy of Sciences 2019cited by 191position: middledoi

Into the clinic: Talimogene laherparepvec (T-VEC), a first-in-class intratumoral oncolytic viral therapy

Journal for ImmunoTherapy of Cancer 2016cited by 363position: middledoi

Grants

CAREER: Human-Centric Automation in the Built Environment

NSF2047317$822,0632021–2026PIRePORTER

University of Georgia-Warnell School of Forestry and Natural Resources Proposal for Participation in the NSF Center for Advanced Forestry Systems

NSF0855776$357,9952009–2015PIRePORTER

Frequent collaborators

Ann W. Silk · Dana-Farber Cancer Institute1 papers (2016–2016)Hasan Rehman · National University of Sciences and Technology1 papers (2016–2016)Howard L. Kaufman · Q Therapeutics (United States)1 papers (2016–2016)